Literature DB >> 33669985

Handling Poor Accrual in Pediatric Trials: A Simulation Study Using a Bayesian Approach.

Danila Azzolina1,2, Giulia Lorenzoni1, Silvia Bressan3, Liviana Da Dalt3, Ileana Baldi1, Dario Gregori1.   

Abstract

In the conduction of trials, a common situation is related to potential difficulties in recruiting the planned sample size as provided by the study design. A Bayesian analysis of such trials might provide a framework to combine prior evidence with current evidence, and it is an accepted approach by regulatory agencies. However, especially for small trials, the Bayesian inference may be severely conditioned by the prior choices. The Renal Scarring Urinary Infection (RESCUE) trial, a pediatric trial that was a candidate for early termination due to underrecruitment, served as a motivating example to investigate the effects of the prior choices on small trial inference. The trial outcomes were simulated by assuming 50 scenarios combining different sample sizes and true absolute risk reduction (ARR). The simulated data were analyzed via the Bayesian approach using 0%, 50%, and 100% discounting factors on the beta power prior. An informative inference (0% discounting) on small samples could generate data-insensitive results. Instead, the 50% discounting factor ensured that the probability of confirming the trial outcome was higher than 80%, but only for an ARR higher than 0.17. A suitable option to maintain data relevant to the trial inference is to define a discounting factor based on the prior parameters. Nevertheless, a sensitivity analysis of the prior choices is highly recommended.

Entities:  

Keywords:  Bayesian trial; poor accrual; power-prior

Year:  2021        PMID: 33669985      PMCID: PMC7924849          DOI: 10.3390/ijerph18042095

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  29 in total

1.  The prevalence and economic impact of low-enrolling clinical studies at an academic medical center.

Authors:  Darlene R Kitterman; Steven K Cheng; David M Dilts; Eric S Orwoll
Journal:  Acad Med       Date:  2011-11       Impact factor: 6.893

2.  Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study.

Authors:  Claudia Pedroza; Weilu Han; Van Thi Thanh Truong; Charles Green; Jon E Tyson
Journal:  Stat Methods Med Res       Date:  2015-12-13       Impact factor: 3.021

3.  Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial.

Authors:  Nader Shaikh; Timothy R Shope; Alejandro Hoberman; Gysella B Muniz; Sonika Bhatnagar; Andrew Nowalk; Robert W Hickey; Marian G Michaels; Diana Kearney; Howard E Rockette; Martin Charron; Ruth Lim; Massoud Majd; Eglal Shalaby-Rana; Marcia Kurs-Lasky; Daniel M Cohen; Ellen R Wald; Greg Lockhart; Hans G Pohl; Judith M Martin
Journal:  Pediatr Nephrol       Date:  2020-06-15       Impact factor: 3.714

4.  Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics.

Authors:  Robin A Huff; Jeff D Maca; Mala Puri; Earl W Seltzer
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

5.  Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children.

Authors:  Natalie Pica; Florence Bourgeois
Journal:  Pediatrics       Date:  2016-08-04       Impact factor: 7.124

6.  Research: An event or an environment?

Authors:  Roberts S Mannel; Kathleen Moore
Journal:  Gynecol Oncol       Date:  2014-09       Impact factor: 5.482

7.  Bayesian clinical trial design using historical data that inform the treatment effect.

Authors:  Matthew A Psioda; Joseph G Ibrahim
Journal:  Biostatistics       Date:  2019-07-01       Impact factor: 5.899

8.  Dynamic borrowing through empirical power priors that control type I error.

Authors:  Stavros Nikolakopoulos; Ingeborg van der Tweel; Kit C B Roes
Journal:  Biometrics       Date:  2017-12-11       Impact factor: 2.571

9.  Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring.

Authors:  Ya-Yun Huang; Mei-Ju Chen; Nan-Tsing Chiu; Hsin-Hsu Chou; Kuang-Yen Lin; Yuan-Yow Chiou
Journal:  Pediatrics       Date:  2011-08-15       Impact factor: 7.124

10.  Early termination of cardiovascular trials as a consequence of poor accrual: analysis of ClinicalTrials.gov 2006-2015.

Authors:  Ileana Baldi; Corrado Lanera; Paola Berchialla; Dario Gregori
Journal:  BMJ Open       Date:  2017-06-15       Impact factor: 2.692

View more
  1 in total

1.  Oral steroids for reducing kidney scarring in young children with febrile urinary tract infections: the contribution of Bayesian analysis to a randomized trial not reaching its intended sample size.

Authors:  Liviana Da Dalt; Silvia Bressan; Floriana Scozzola; Enrico Vidal; Monia Gennari; Claudio La Scola; Mauro Anselmi; Elisabetta Miorin; Pietro Zucchetta; Danila Azzolina; Dario Gregori; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2021-05-25       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.